0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pertussis Vaccine Market Insights and Forecast to 2028
Published Date: January 2022
|
Report Code: QYRE-Othe-4136
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Global Pertussis Vaccine Market Insights and Forecast to 2028

Global Pertussis Vaccine Market Insights and Forecast to 2028

Code: QYRE-Othe-4136
Report
January 2022
90 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
Market Analysis and Insights: Global Pertussis Vaccine Market

Due to the COVID-19 pandemic, the global Pertussis Vaccine market size is estimated to be worth US$ 5384.9 million in 2022 and is forecast to a readjusted size of US$ 6619.4 million by 2028 with a CAGR of 3.5% during the review period.

Fully considering the economic change by this health crisis, Whole-cell Vaccines accounting for % of the Pertussis Vaccine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While 12 Months Below segment is altered to an % CAGR throughout this forecast period.
Global pertussis vaccine key players include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology etc. Global top 2 manufacturers hold a share about 90%. Europe is the largest market, with a share over 30%, followed by North America.
Global Pertussis Vaccine Scope and Segment
Pertussis Vaccine market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Pertussis Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Whole-cell Vaccines
Acellular Vaccines

Segment by Application

12 Months Below
12 Months Above

BY COMPANY

Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
Wuhan Institute of Biological Products
Walvax Biotechnology
Minhai Biotechnology
KM Biologics
Chengdu Institute of Biological Products

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
1 Study Coverage
1.1 Pertussis Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Pertussis Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Whole-cell Vaccines
1.2.3 Acellular Vaccines
1.3 Market by Application
1.3.1 Global Pertussis Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 12 Months Below
1.3.3 12 Months Above
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pertussis Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Pertussis Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Pertussis Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Pertussis Vaccine Sales by Region
2.4.1 Global Pertussis Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Pertussis Vaccine by Region (2023-2028)
2.5 Global Pertussis Vaccine Revenue by Region
2.5.1 Global Pertussis Vaccine Revenue by Region (2017-2022)
2.5.2 Global Pertussis Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Pertussis Vaccine Sales by Manufacturers
3.1.1 Global Top Pertussis Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Pertussis Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pertussis Vaccine in 2021
3.2 Global Pertussis Vaccine Revenue by Manufacturers
3.2.1 Global Pertussis Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Pertussis Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Pertussis Vaccine Revenue in 2021
3.3 Global Pertussis Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Pertussis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Pertussis Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pertussis Vaccine Sales by Type
4.1.1 Global Pertussis Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Pertussis Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Pertussis Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Pertussis Vaccine Revenue by Type
4.2.1 Global Pertussis Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Pertussis Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Pertussis Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Pertussis Vaccine Price by Type
4.3.1 Global Pertussis Vaccine Price by Type (2017-2022)
4.3.2 Global Pertussis Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Pertussis Vaccine Sales by Application
5.1.1 Global Pertussis Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Pertussis Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Pertussis Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Pertussis Vaccine Revenue by Application
5.2.1 Global Pertussis Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Pertussis Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Pertussis Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Pertussis Vaccine Price by Application
5.3.1 Global Pertussis Vaccine Price by Application (2017-2022)
5.3.2 Global Pertussis Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Pertussis Vaccine Market Size by Type
6.1.1 North America Pertussis Vaccine Sales by Type (2017-2028)
6.1.2 North America Pertussis Vaccine Revenue by Type (2017-2028)
6.2 North America Pertussis Vaccine Market Size by Application
6.2.1 North America Pertussis Vaccine Sales by Application (2017-2028)
6.2.2 North America Pertussis Vaccine Revenue by Application (2017-2028)
6.3 North America Pertussis Vaccine Market Size by Country
6.3.1 North America Pertussis Vaccine Sales by Country (2017-2028)
6.3.2 North America Pertussis Vaccine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Pertussis Vaccine Market Size by Type
7.1.1 Europe Pertussis Vaccine Sales by Type (2017-2028)
7.1.2 Europe Pertussis Vaccine Revenue by Type (2017-2028)
7.2 Europe Pertussis Vaccine Market Size by Application
7.2.1 Europe Pertussis Vaccine Sales by Application (2017-2028)
7.2.2 Europe Pertussis Vaccine Revenue by Application (2017-2028)
7.3 Europe Pertussis Vaccine Market Size by Country
7.3.1 Europe Pertussis Vaccine Sales by Country (2017-2028)
7.3.2 Europe Pertussis Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Pertussis Vaccine Market Size by Type
8.1.1 Asia Pacific Pertussis Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Pertussis Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Pertussis Vaccine Market Size by Application
8.2.1 Asia Pacific Pertussis Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Pertussis Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Pertussis Vaccine Market Size by Region
8.3.1 Asia Pacific Pertussis Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Pertussis Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Pertussis Vaccine Market Size by Type
9.1.1 Latin America Pertussis Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Pertussis Vaccine Revenue by Type (2017-2028)
9.2 Latin America Pertussis Vaccine Market Size by Application
9.2.1 Latin America Pertussis Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Pertussis Vaccine Revenue by Application (2017-2028)
9.3 Latin America Pertussis Vaccine Market Size by Country
9.3.1 Latin America Pertussis Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Pertussis Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Pertussis Vaccine Market Size by Type
10.1.1 Middle East and Africa Pertussis Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Pertussis Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Pertussis Vaccine Market Size by Application
10.2.1 Middle East and Africa Pertussis Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Pertussis Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Pertussis Vaccine Market Size by Country
10.3.1 Middle East and Africa Pertussis Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Pertussis Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sanofi Pasteur
11.1.1 Sanofi Pasteur Corporation Information
11.1.2 Sanofi Pasteur Overview
11.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sanofi Pasteur Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Pasteur Recent Developments
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Overview
11.2.3 GSK Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 GSK Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GSK Recent Developments
11.3 Mitsubishi Tanabe Pharma
11.3.1 Mitsubishi Tanabe Pharma Corporation Information
11.3.2 Mitsubishi Tanabe Pharma Overview
11.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Mitsubishi Tanabe Pharma Recent Developments
11.4 Wuhan Institute of Biological Products
11.4.1 Wuhan Institute of Biological Products Corporation Information
11.4.2 Wuhan Institute of Biological Products Overview
11.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Wuhan Institute of Biological Products Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Wuhan Institute of Biological Products Recent Developments
11.5 Walvax Biotechnology
11.5.1 Walvax Biotechnology Corporation Information
11.5.2 Walvax Biotechnology Overview
11.5.3 Walvax Biotechnology Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Walvax Biotechnology Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Walvax Biotechnology Recent Developments
11.6 Minhai Biotechnology
11.6.1 Minhai Biotechnology Corporation Information
11.6.2 Minhai Biotechnology Overview
11.6.3 Minhai Biotechnology Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Minhai Biotechnology Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Minhai Biotechnology Recent Developments
11.7 KM Biologics
11.7.1 KM Biologics Corporation Information
11.7.2 KM Biologics Overview
11.7.3 KM Biologics Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 KM Biologics Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 KM Biologics Recent Developments
11.8 Chengdu Institute of Biological Products
11.8.1 Chengdu Institute of Biological Products Corporation Information
11.8.2 Chengdu Institute of Biological Products Overview
11.8.3 Chengdu Institute of Biological Products Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Chengdu Institute of Biological Products Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Chengdu Institute of Biological Products Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pertussis Vaccine Industry Chain Analysis
12.2 Pertussis Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pertussis Vaccine Production Mode & Process
12.4 Pertussis Vaccine Sales and Marketing
12.4.1 Pertussis Vaccine Sales Channels
12.4.2 Pertussis Vaccine Distributors
12.5 Pertussis Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Pertussis Vaccine Industry Trends
13.2 Pertussis Vaccine Market Drivers
13.3 Pertussis Vaccine Market Challenges
13.4 Pertussis Vaccine Market Restraints
14 Key Findings in The Global Pertussis Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Pertussis Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Whole-cell Vaccines
    Table 3. Major Manufacturers of Acellular Vaccines
    Table 4. Global Pertussis Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Pertussis Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Pertussis Vaccine Sales by Region (2017-2022) & (M Doses)
    Table 7. Global Pertussis Vaccine Sales Market Share by Region (2017-2022)
    Table 8. Global Pertussis Vaccine Sales by Region (2023-2028) & (M Doses)
    Table 9. Global Pertussis Vaccine Sales Market Share by Region (2023-2028)
    Table 10. Global Pertussis Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Pertussis Vaccine Revenue Market Share by Region (2017-2022)
    Table 12. Global Pertussis Vaccine Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Pertussis Vaccine Revenue Market Share by Region (2023-2028)
    Table 14. Global Pertussis Vaccine Sales by Manufacturers (2017-2022) & (M Doses)
    Table 15. Global Pertussis Vaccine Sales Share by Manufacturers (2017-2022)
    Table 16. Global Pertussis Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Pertussis Vaccine Revenue Share by Manufacturers (2017-2022)
    Table 18. Pertussis Vaccine Price by Manufacturers (2017-2022) &(USD/Doses)
    Table 19. Global Pertussis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Pertussis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pertussis Vaccine as of 2021)
    Table 21. Pertussis Vaccine Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Pertussis Vaccine Product Offered
    Table 23. Date of Manufacturers Enter into Pertussis Vaccine Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Pertussis Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 26. Global Pertussis Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 27. Global Pertussis Vaccine Sales Share by Type (2017-2022)
    Table 28. Global Pertussis Vaccine Sales Share by Type (2023-2028)
    Table 29. Global Pertussis Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Pertussis Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Pertussis Vaccine Revenue Share by Type (2017-2022)
    Table 32. Global Pertussis Vaccine Revenue Share by Type (2023-2028)
    Table 33. Pertussis Vaccine Price by Type (2017-2022) & (USD/Doses)
    Table 34. Global Pertussis Vaccine Price Forecast by Type (2023-2028) & (USD/Doses)
    Table 35. Global Pertussis Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 36. Global Pertussis Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 37. Global Pertussis Vaccine Sales Share by Application (2017-2022)
    Table 38. Global Pertussis Vaccine Sales Share by Application (2023-2028)
    Table 39. Global Pertussis Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Pertussis Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Pertussis Vaccine Revenue Share by Application (2017-2022)
    Table 42. Global Pertussis Vaccine Revenue Share by Application (2023-2028)
    Table 43. Pertussis Vaccine Price by Application (2017-2022) & (USD/Doses)
    Table 44. Global Pertussis Vaccine Price Forecast by Application (2023-2028) & (USD/Doses)
    Table 45. North America Pertussis Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 46. North America Pertussis Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 47. North America Pertussis Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Pertussis Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Pertussis Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 50. North America Pertussis Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 51. North America Pertussis Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Pertussis Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Pertussis Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 54. North America Pertussis Vaccine Sales by Country (2023-2028) & (M Doses)
    Table 55. North America Pertussis Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Pertussis Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Pertussis Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 58. Europe Pertussis Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 59. Europe Pertussis Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Pertussis Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Pertussis Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 62. Europe Pertussis Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 63. Europe Pertussis Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Pertussis Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Pertussis Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 66. Europe Pertussis Vaccine Sales by Country (2023-2028) & (M Doses)
    Table 67. Europe Pertussis Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Pertussis Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Pertussis Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 70. Asia Pacific Pertussis Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 71. Asia Pacific Pertussis Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Pertussis Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Pertussis Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 74. Asia Pacific Pertussis Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 75. Asia Pacific Pertussis Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Pertussis Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Pertussis Vaccine Sales by Region (2017-2022) & (M Doses)
    Table 78. Asia Pacific Pertussis Vaccine Sales by Region (2023-2028) & (M Doses)
    Table 79. Asia Pacific Pertussis Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Pertussis Vaccine Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Pertussis Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 82. Latin America Pertussis Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 83. Latin America Pertussis Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Pertussis Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Pertussis Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 86. Latin America Pertussis Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 87. Latin America Pertussis Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Pertussis Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Pertussis Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 90. Latin America Pertussis Vaccine Sales by Country (2023-2028) & (M Doses)
    Table 91. Latin America Pertussis Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Pertussis Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Pertussis Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 94. Middle East and Africa Pertussis Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 95. Middle East and Africa Pertussis Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Pertussis Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Pertussis Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 98. Middle East and Africa Pertussis Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 99. Middle East and Africa Pertussis Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Pertussis Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Pertussis Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 102. Middle East and Africa Pertussis Vaccine Sales by Country (2023-2028) & (M Doses)
    Table 103. Middle East and Africa Pertussis Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Pertussis Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Sanofi Pasteur Corporation Information
    Table 106. Sanofi Pasteur Description and Major Businesses
    Table 107. Sanofi Pasteur Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 108. Sanofi Pasteur Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Sanofi Pasteur Recent Developments
    Table 110. GSK Corporation Information
    Table 111. GSK Description and Major Businesses
    Table 112. GSK Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 113. GSK Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. GSK Recent Developments
    Table 115. Mitsubishi Tanabe Pharma Corporation Information
    Table 116. Mitsubishi Tanabe Pharma Description and Major Businesses
    Table 117. Mitsubishi Tanabe Pharma Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 118. Mitsubishi Tanabe Pharma Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Mitsubishi Tanabe Pharma Recent Developments
    Table 120. Wuhan Institute of Biological Products Corporation Information
    Table 121. Wuhan Institute of Biological Products Description and Major Businesses
    Table 122. Wuhan Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 123. Wuhan Institute of Biological Products Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Wuhan Institute of Biological Products Recent Developments
    Table 125. Walvax Biotechnology Corporation Information
    Table 126. Walvax Biotechnology Description and Major Businesses
    Table 127. Walvax Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 128. Walvax Biotechnology Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Walvax Biotechnology Recent Developments
    Table 130. Minhai Biotechnology Corporation Information
    Table 131. Minhai Biotechnology Description and Major Businesses
    Table 132. Minhai Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 133. Minhai Biotechnology Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Minhai Biotechnology Recent Developments
    Table 135. KM Biologics Corporation Information
    Table 136. KM Biologics Description and Major Businesses
    Table 137. KM Biologics Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 138. KM Biologics Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. KM Biologics Recent Developments
    Table 140. Chengdu Institute of Biological Products Corporation Information
    Table 141. Chengdu Institute of Biological Products Description and Major Businesses
    Table 142. Chengdu Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 143. Chengdu Institute of Biological Products Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Chengdu Institute of Biological Products Recent Developments
    Table 145. Key Raw Materials Lists
    Table 146. Raw Materials Key Suppliers Lists
    Table 147. Pertussis Vaccine Distributors List
    Table 148. Pertussis Vaccine Customers List
    Table 149. Pertussis Vaccine Market Trends
    Table 150. Pertussis Vaccine Market Drivers
    Table 151. Pertussis Vaccine Market Challenges
    Table 152. Pertussis Vaccine Market Restraints
    Table 153. Research Programs/Design for This Report
    Table 154. Key Data Information from Secondary Sources
    Table 155. Key Data Information from Primary Sources
List of Figures
    Figure 1. Pertussis Vaccine Product Picture
    Figure 3. Global Pertussis Vaccine Market Share by Type in 2021 & 2028
    Figure 3. Whole-cell Vaccines Product Picture
    Figure 4. Acellular Vaccines Product Picture
    Figure 5. Global Pertussis Vaccine Market Share by Application in 2021 & 2028
    Figure 6. 12 Months Below
    Figure 7. 12 Months Above
    Figure 8. Pertussis Vaccine Report Years Considered
    Figure 9. Global Pertussis Vaccine Sales 2017-2028 (M Doses)
    Figure 10. Global Pertussis Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Pertussis Vaccine Revenue 2017-2028 (US$ Million)
    Figure 12. Global Pertussis Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 13. Global Pertussis Vaccine Sales Market Share by Region (2017-2022)
    Figure 14. Global Pertussis Vaccine Sales Market Share by Region (2023-2028)
    Figure 15. North America Pertussis Vaccine Sales YoY (2017-2028) & (M Doses)
    Figure 16. North America Pertussis Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 17. Europe Pertussis Vaccine Sales YoY (2017-2028) & (M Doses)
    Figure 18. Europe Pertussis Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Asia-Pacific Pertussis Vaccine Sales YoY (2017-2028) & (M Doses)
    Figure 20. Asia-Pacific Pertussis Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Latin America Pertussis Vaccine Sales YoY (2017-2028) & (M Doses)
    Figure 22. Latin America Pertussis Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Middle East & Africa Pertussis Vaccine Sales YoY (2017-2028) & (M Doses)
    Figure 24. Middle East & Africa Pertussis Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. The Pertussis Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 26. The Top 5 and 10 Largest Manufacturers of Pertussis Vaccine in the World: Market Share by Pertussis Vaccine Revenue in 2021
    Figure 27. Global Pertussis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 28. Global Pertussis Vaccine Sales Market Share by Type (2017-2028)
    Figure 29. Global Pertussis Vaccine Revenue Market Share by Type (2017-2028)
    Figure 30. Global Pertussis Vaccine Sales Market Share by Application (2017-2028)
    Figure 31. Global Pertussis Vaccine Revenue Market Share by Application (2017-2028)
    Figure 32. North America Pertussis Vaccine Sales Market Share by Type (2017-2028)
    Figure 33. North America Pertussis Vaccine Revenue Market Share by Type (2017-2028)
    Figure 34. North America Pertussis Vaccine Sales Market Share by Application (2017-2028)
    Figure 35. North America Pertussis Vaccine Revenue Market Share by Application (2017-2028)
    Figure 36. North America Pertussis Vaccine Sales Share by Country (2017-2028)
    Figure 37. North America Pertussis Vaccine Revenue Share by Country (2017-2028)
    Figure 38. U.S. Pertussis Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 39. Canada Pertussis Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 40. Europe Pertussis Vaccine Sales Market Share by Type (2017-2028)
    Figure 41. Europe Pertussis Vaccine Revenue Market Share by Type (2017-2028)
    Figure 42. Europe Pertussis Vaccine Sales Market Share by Application (2017-2028)
    Figure 43. Europe Pertussis Vaccine Revenue Market Share by Application (2017-2028)
    Figure 44. Europe Pertussis Vaccine Sales Share by Country (2017-2028)
    Figure 45. Europe Pertussis Vaccine Revenue Share by Country (2017-2028)
    Figure 46. Germany Pertussis Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 47. France Pertussis Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 48. U.K. Pertussis Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 49. Italy Pertussis Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 50. Russia Pertussis Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 51. Asia Pacific Pertussis Vaccine Sales Market Share by Type (2017-2028)
    Figure 52. Asia Pacific Pertussis Vaccine Revenue Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Pertussis Vaccine Sales Market Share by Application (2017-2028)
    Figure 54. Asia Pacific Pertussis Vaccine Revenue Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Pertussis Vaccine Sales Share by Region (2017-2028)
    Figure 56. Asia Pacific Pertussis Vaccine Revenue Share by Region (2017-2028)
    Figure 57. China Pertussis Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 58. Japan Pertussis Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 59. South Korea Pertussis Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 60. India Pertussis Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 61. Australia Pertussis Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 62. Taiwan Pertussis Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 63. Indonesia Pertussis Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 64. Thailand Pertussis Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 65. Malaysia Pertussis Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 66. Philippines Pertussis Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 67. Latin America Pertussis Vaccine Sales Market Share by Type (2017-2028)
    Figure 68. Latin America Pertussis Vaccine Revenue Market Share by Type (2017-2028)
    Figure 69. Latin America Pertussis Vaccine Sales Market Share by Application (2017-2028)
    Figure 70. Latin America Pertussis Vaccine Revenue Market Share by Application (2017-2028)
    Figure 71. Latin America Pertussis Vaccine Sales Share by Country (2017-2028)
    Figure 72. Latin America Pertussis Vaccine Revenue Share by Country (2017-2028)
    Figure 73. Mexico Pertussis Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 74. Brazil Pertussis Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 75. Argentina Pertussis Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 76. Middle East and Africa Pertussis Vaccine Sales Market Share by Type (2017-2028)
    Figure 77. Middle East and Africa Pertussis Vaccine Revenue Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Pertussis Vaccine Sales Market Share by Application (2017-2028)
    Figure 79. Middle East and Africa Pertussis Vaccine Revenue Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Pertussis Vaccine Sales Share by Country (2017-2028)
    Figure 81. Middle East and Africa Pertussis Vaccine Revenue Share by Country (2017-2028)
    Figure 82. Turkey Pertussis Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 83. Saudi Arabia Pertussis Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 84. U.A.E Pertussis Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 85. Pertussis Vaccine Value Chain
    Figure 86. Pertussis Vaccine Production Process
    Figure 87. Channels of Distribution
    Figure 88. Distributors Profiles
    Figure 89. Bottom-up and Top-down Approaches for This Report
    Figure 90. Data Triangulation
    Figure 91. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user to access the PDF.

Electronic (PDF)
$7350
This license allows multiple user to access the PDF.

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Leap India
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Add to Cart

Global Hepatitis C Drugs Market Insights Forecast to 2028
Global Hepatitis C Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-1B6342
Mon Dec 05 00:00:00 UTC 2022

Add to Cart

Global Influenza Vaccination Market Insights Forecast to 2028
Global Influenza Vaccination Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-12M6165
Mon Dec 05 00:00:00 UTC 2022

Add to Cart

Global Infectious Disease Treatment Market Insights Forecast to 2028
Global Infectious Disease Treatment Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

120 Pages
Type: Report
Code: QYRE-Othe-2I273
Mon Dec 05 00:00:00 UTC 2022

Add to Cart